Starch-Based Excipient for Direct Compression
StarTab from Colorcon was designed to ensure functionality and stability for direct compression tableting.
Colorcon has introduced StarTab, a starch tableting excipient designed for the direct compression process. The excipient’s particle size and shape are designed to improve flow and compressibility on high-speed compression machines; enabling formulation scientists to simplify tablet formulation and manufacturing, the company reports in a May 16, 2019 press statement.
The excipient also is formulated to enhance the stability of moisture-sensitive APIs.
The company reports that StarTab uses material that is accepted by global regulatory authorities, reducing barriers to adoption of the product.
Source: Colorcon, Inc.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Entering New Domains for 3D Printing of Drug Products
April 6th 20253D printing of personalized medications is currently possible under existing compounding regulations, offering enhanced process control through automation. But new legislation coming in 2025 will allow 3D printing as part of a distributed manufacturing framework.
